{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T17:37:23Z","timestamp":1785173843709,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T00:00:00Z","timestamp":1660089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T00:00:00Z","timestamp":1660089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100016275","name":"Seoul National University Bundang Hospital","doi-asserted-by":"publisher","award":["14-2022-0002"],"award-info":[{"award-number":["14-2022-0002"]}],"id":[{"id":"10.13039\/100016275","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Lymphedema is a progressive disease caused by lymphatic flow blockage in the lymphatic pathway. Primary (hereditary) lymphedema is caused by genetic mutations without secondary causes. We performed clinical profiling on Korean primary lymphedema patients based on their phenotypes using lymphoscintigraphy and made genetic diagnoses using a next-generation sequencing panel consisting of 60 genes known to be related to primary lymphedema and vascular anomalies. Of 27 patients included in this study, 14.8% of the patients had lymphedema of the upper extremities, 77.8% had lymphedema of the lower extremities and 7.4% had 4-limbs lymphedema. Based on the International Society of Lymphology staging, 14, 10, and 3 patients had stage 3, 2, and 1 lymphedema, respectively. Only one family was genetically confirmed to harbor likely pathogenic variants in <jats:italic>CELSR1.<\/jats:italic> The proband was carrying two likely pathogenic variants in <jats:italic>CELSR1<\/jats:italic>, while her symptomatic mother was confirmed to carry only one of the variants. Furthermore, two other variants of uncertain significance in <jats:italic>CELSR1<\/jats:italic> were detected in other patients, making <jats:italic>CELSR1<\/jats:italic> the most commonly altered gene in our study. The clinical and genetic profile of hereditary lymphedema reported here is the first such data series reported for South Korea.<\/jats:p>","DOI":"10.1038\/s41598-022-17958-7","type":"journal-article","created":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T10:02:59Z","timestamp":1660125779000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Clinical staging and genetic profiling of Korean patients with primary lymphedema using targeted gene sequencing"],"prefix":"10.1038","volume":"12","author":[{"given":"Soo Hyun","family":"Seo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seungjun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph Kyu-hyung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Joo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boram","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jee-Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Sup","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moon-Woo","family":"Seong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun-Young","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan-Yeong","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujin","family":"Myung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,10]]},"reference":[{"key":"17958_CR1","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1196\/annals.1413.013","volume":"1131","author":"F Connell","year":"2008","unstructured":"Connell, F., Brice, G. & Mortimer, P. Phenotypic characterization of primary lymphedema. Ann. N. Y. Acad. Sci. 1131, 140\u2013146 (2008).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"17958_CR2","unstructured":"Sleigh, B. C. & Manna, B. Lymphedema (StatPearls Publishing, 2022)."},{"key":"17958_CR3","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1089\/wound.2020.1338","volume":"11","author":"CL Sudduth","year":"2022","unstructured":"Sudduth, C. L. & Greene, A. K. Primary lymphedema: Update on genetic basis and management. Adv. Wound Care 11, 374\u2013381 (2022).","journal-title":"Adv. Wound Care"},{"key":"17958_CR4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1196\/annals.1413.014","volume":"1131","author":"SG Rockson","year":"2008","unstructured":"Rockson, S. G. & Rivera, K. K. Estimating the population burden of lymphedema. Ann. N. Y. Acad. Sci. 1131, 147\u2013154 (2008).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"17958_CR5","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/jnu.12117","volume":"47","author":"J Deng","year":"2015","unstructured":"Deng, J. et al. Self-care status, symptom burden, and reported infections in individuals with lower-extremity primary lymphedema. J. Nurs. Scholarsh. 47, 126\u2013134 (2015).","journal-title":"J. Nurs. Scholarsh."},{"key":"17958_CR6","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1203\/00006450-200211000-00003","volume":"52","author":"S Grunewald","year":"2002","unstructured":"Grunewald, S., Matthijs, G. & Jaeken, J. Congenital disorders of glycosylation: a review. Pediatr. Res. 52, 618\u2013624 (2002).","journal-title":"Pediatr. Res."},{"key":"17958_CR7","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1097\/PRS.0b013e318213a218","volume":"127","author":"CC Schook","year":"2011","unstructured":"Schook, C. C. et al. Primary lymphedema: clinical features and management in 138 pediatric patients. Plast. Reconstr. Surg. 127, 2419\u20132431 (2011).","journal-title":"Plast. Reconstr. Surg."},{"key":"17958_CR8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/cge.13204","volume":"94","author":"E Fastr\u00e9","year":"2018","unstructured":"Fastr\u00e9, E. et al. Splice-site mutations in VEGFC cause loss of function and Nonne-Milroy-like primary lymphedema. Clin. Genet. 94, 179\u2013181 (2018).","journal-title":"Clin. Genet."},{"key":"17958_CR9","first-page":"309","volume":"24","author":"S Kitsiou-Tzeli","year":"2010","unstructured":"Kitsiou-Tzeli, S. et al. Milroy\u2019s primary congenital lymphedema in a male infant and review of the literature. In Vivo 24, 309\u2013314 (2010).","journal-title":"In Vivo"},{"key":"17958_CR10","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1136\/jmg.2004.024802","volume":"42","author":"G Brice","year":"2005","unstructured":"Brice, G. et al. Milroy disease and the VEGFR-3 mutation phenotype. J. Med. Genet. 42, 98\u2013102 (2005).","journal-title":"J. Med. Genet."},{"key":"17958_CR11","first-page":"145","volume":"31","author":"MH Witte","year":"1998","unstructured":"Witte, M. H. et al. Phenotypic and genotypic heterogeneity in familial Milroy lymphedema. Lymphology 31, 145\u2013155 (1998).","journal-title":"Lymphology"},{"key":"17958_CR12","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1001\/jama.1928.02700160024005","volume":"91","author":"WF Milroy","year":"1928","unstructured":"Milroy, W. F. Chronic hereditary edema: Milroy\u2019s disease. JAMA 91, 1172\u20131175 (1928).","journal-title":"JAMA"},{"key":"17958_CR13","unstructured":"Milroy, W. F. An Undescribed Variety of Hereditary Oedema (Appleton, 1892)."},{"key":"17958_CR14","first-page":"541","volume":"32","author":"BB Lee","year":"2013","unstructured":"Lee, B. B. et al. Diagnosis and treatment of primary lymphedema. Consensus document of the International Union of Phlebology (IUP)-2013. Int. Angiol. 32, 541\u2013574 (2013).","journal-title":"Int. Angiol."},{"key":"17958_CR15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1159\/000354097","volume":"4","author":"A Mendola","year":"2013","unstructured":"Mendola, A. et al. Mutations in the VEGFR3 signaling pathway explain 36% of familial lymphedema. Mol. Syndromol. 4, 257\u2013266 (2013).","journal-title":"Mol. Syndromol."},{"key":"17958_CR16","first-page":"57","volume":"49","author":"S Michelini","year":"2016","unstructured":"Michelini, S. et al. Genetic screening in a large cohort of Italian patients affected by primary lymphedema using a next generation sequencing (NGS) approach. Lymphology 49, 57\u201372 (2016).","journal-title":"Lymphology"},{"key":"17958_CR17","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41572-021-00309-7","volume":"7","author":"P Brouillard","year":"2021","unstructured":"Brouillard, P. et al. Primary lymphoedema. Nat. Rev. Dis. Primers 7, 77 (2021).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"17958_CR18","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2214\/ajr.144.2.361","volume":"144","author":"NS Hadjis","year":"1985","unstructured":"Hadjis, N. S., Carr, D. H., Banks, L. & Pflug, J. J. The role of CT in the diagnosis of primary lymphedema of the lower limb. Am. J. Roentgenol. 144, 361\u2013364 (1985).","journal-title":"Am. J. Roentgenol."},{"key":"17958_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13221-016-0035-5","volume":"8","author":"ML Gonzalez-Garay","year":"2016","unstructured":"Gonzalez-Garay, M. L. et al. A novel mutation in CELSR1 is associated with hereditary lymphedema. Vasc. Cell 8, 1 (2016).","journal-title":"Vasc. Cell"},{"key":"17958_CR20","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/cge.13622","volume":"96","author":"RP Erickson","year":"2019","unstructured":"Erickson, R. P. et al. Sex-limited penetrance of lymphedema to females with CELSR1 haploinsufficiency: A second family. Clin. Genet. 96, 478\u2013482 (2019).","journal-title":"Clin. Genet."},{"key":"17958_CR21","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1002\/ajmg.a.61269","volume":"179","author":"PE Maltese","year":"2019","unstructured":"Maltese, P. E. et al. Increasing evidence of hereditary lymphedema caused by CELSR1 loss-of-function variants. Am. J. Med. Genet. A 179, 1718\u20131724 (2019).","journal-title":"Am. J. Med. Genet. A"},{"key":"17958_CR22","doi-asserted-by":"crossref","unstructured":"Xia, S. et al. Lymphedema complicated by protein-losing enteropathy with a 22q13. 3 Deletion and the potential role of CELSR1: a case report. Medicine 100, e26307 (2021).","DOI":"10.1097\/MD.0000000000026307"},{"key":"17958_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000728","volume":"4","author":"PT Cantey","year":"2010","unstructured":"Cantey, P. T., Rout, J., Rao, G., Williamson, J. & Fox, L. M. Increasing compliance with mass drug administration programs for lymphatic filariasis in India through education and lymphedema management programs. PLOS Negl. Trop. Dis. 4, e728 (2010).","journal-title":"PLOS Negl. Trop. Dis."},{"key":"17958_CR24","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3347\/kjp.2008.46.3.119","volume":"46","author":"RK Shenoy","year":"2008","unstructured":"Shenoy, R. K. Clinical and pathological aspects of filarial lymphedema and its management. Korean J. Parasitol. 46, 119\u2013125 (2008).","journal-title":"Korean J. Parasitol."},{"key":"17958_CR25","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/SAP.0000000000002862","volume":"88","author":"F Fallahian","year":"2022","unstructured":"Fallahian, F., Tadisina, K. K. & Xu, K. Y. Efficacy of microsurgical treatment of primary lymphedema: A systematic review. Ann. Plast. Surg. 88, 195\u2013199 (2022).","journal-title":"Ann. Plast. Surg."},{"key":"17958_CR26","first-page":"170","volume":"49","author":"E Committee","year":"2016","unstructured":"Committee, E. The diagnosis and treatment of peripheral lymphedema: 2016 consensus document of the International Society of Lymphology. Lymphology 49, 170\u2013184 (2016).","journal-title":"Lymphology"},{"key":"17958_CR27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405\u2013424 (2015).","journal-title":"Genet. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-17958-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-17958-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-17958-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T06:54:04Z","timestamp":1669359244000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-17958-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,10]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["17958"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-17958-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,10]]},"assertion":[{"value":"26 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13591"}}